Cargando…
Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure
OBJECTIVES: To measure the mass transfer and clearance of procalcitonin (PCT) in patients with septic shock during continuous venovenous hemofiltration (CVVH), and to assess the mechanisms of elimination of PCT. SETTING: The medical department of intensive care. DESIGN: A prospective, observational...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC374372/ https://www.ncbi.nlm.nih.gov/pubmed/14624691 |
_version_ | 1782121279456804864 |
---|---|
author | Level, Claude Chauveau, Philippe Guisset, Olivier Cazin, Marie Cécile Lasseur, Catherine Gabinsky, Claude Winnock, Stéphane Montaudon, Danièle Bedry, Régis Nouts, Caroline Pillet, Odile Benissan, Georges Gbikpi Favarel-Guarrigues, Jean Claude Castaing, Yves |
author_facet | Level, Claude Chauveau, Philippe Guisset, Olivier Cazin, Marie Cécile Lasseur, Catherine Gabinsky, Claude Winnock, Stéphane Montaudon, Danièle Bedry, Régis Nouts, Caroline Pillet, Odile Benissan, Georges Gbikpi Favarel-Guarrigues, Jean Claude Castaing, Yves |
author_sort | Level, Claude |
collection | PubMed |
description | OBJECTIVES: To measure the mass transfer and clearance of procalcitonin (PCT) in patients with septic shock during continuous venovenous hemofiltration (CVVH), and to assess the mechanisms of elimination of PCT. SETTING: The medical department of intensive care. DESIGN: A prospective, observational study. PATIENTS: Thirteen critically ill patients with septic shock and oliguric acute renal failure requiring continuous venovenous postdilution hemofiltration with a high-flux membrane (AN69 or polyamide) and a 'conventional' substitution volume (< 2.5 l/hour). MEASUREMENTS AND MAIN RESULTS: PCT was measured with the Lumitest PCT Brahms(® )in the prefilter and postfilter plasma, in the ultrafiltrate at the beginning of CVVH (T0) and 15 min (T15'), 60 min (T60') and 6 hours (T6h) after setup of CVVH, and in the prefilter every 24 hours during 4 days. Mass transfer was determined and the clearance and the sieving coefficient were calculated according to the mass conservation principle. Plasma and ultrafiltrate clearances, respectively, at T15', T60' and T6h were 37 ± 8.6 ml/min (not significant) and 1.8 ± 1.7 ml/min (P < 0.01), 34.7 ± 4.1 ml/min (not significant) and 2.3 ± 1.8 ml/min (P < 0.01), and 31.5 ± 7 ml/min (not significant) and 5 ± 2.3 ml/min (P < 0.01). The sieving coefficient significantly increased from 0.07 at T15' to 0.19 at T6h, with no difference according to the nature of the membrane. PCT plasma levels were not significantly modified during the course of CCVH. CONCLUSIONS: We conclude that PCT is removed from the plasma of patients with septic shock during CCVH. Most of the mass is eliminated by convective flow, but adsorption also contributes to elimination during the first hours of CVVH. The effect of PCT removal with a conventional CVVH substitution fluid rate (<2.5 l/hour) on PCT plasma concentration seems to be limited, and PCT remains a useful diagnostic marker in these septic patients. The impact of high-volume hemofiltration on the PCT clearance, the mass transfer and the plasma concentration should be evaluated in further studies. |
format | Text |
id | pubmed-374372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-3743722004-03-25 Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure Level, Claude Chauveau, Philippe Guisset, Olivier Cazin, Marie Cécile Lasseur, Catherine Gabinsky, Claude Winnock, Stéphane Montaudon, Danièle Bedry, Régis Nouts, Caroline Pillet, Odile Benissan, Georges Gbikpi Favarel-Guarrigues, Jean Claude Castaing, Yves Crit Care Research OBJECTIVES: To measure the mass transfer and clearance of procalcitonin (PCT) in patients with septic shock during continuous venovenous hemofiltration (CVVH), and to assess the mechanisms of elimination of PCT. SETTING: The medical department of intensive care. DESIGN: A prospective, observational study. PATIENTS: Thirteen critically ill patients with septic shock and oliguric acute renal failure requiring continuous venovenous postdilution hemofiltration with a high-flux membrane (AN69 or polyamide) and a 'conventional' substitution volume (< 2.5 l/hour). MEASUREMENTS AND MAIN RESULTS: PCT was measured with the Lumitest PCT Brahms(® )in the prefilter and postfilter plasma, in the ultrafiltrate at the beginning of CVVH (T0) and 15 min (T15'), 60 min (T60') and 6 hours (T6h) after setup of CVVH, and in the prefilter every 24 hours during 4 days. Mass transfer was determined and the clearance and the sieving coefficient were calculated according to the mass conservation principle. Plasma and ultrafiltrate clearances, respectively, at T15', T60' and T6h were 37 ± 8.6 ml/min (not significant) and 1.8 ± 1.7 ml/min (P < 0.01), 34.7 ± 4.1 ml/min (not significant) and 2.3 ± 1.8 ml/min (P < 0.01), and 31.5 ± 7 ml/min (not significant) and 5 ± 2.3 ml/min (P < 0.01). The sieving coefficient significantly increased from 0.07 at T15' to 0.19 at T6h, with no difference according to the nature of the membrane. PCT plasma levels were not significantly modified during the course of CCVH. CONCLUSIONS: We conclude that PCT is removed from the plasma of patients with septic shock during CCVH. Most of the mass is eliminated by convective flow, but adsorption also contributes to elimination during the first hours of CVVH. The effect of PCT removal with a conventional CVVH substitution fluid rate (<2.5 l/hour) on PCT plasma concentration seems to be limited, and PCT remains a useful diagnostic marker in these septic patients. The impact of high-volume hemofiltration on the PCT clearance, the mass transfer and the plasma concentration should be evaluated in further studies. BioMed Central 2003 2003-10-02 /pmc/articles/PMC374372/ /pubmed/14624691 Text en Copyright © 2003 Level et al., licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Level, Claude Chauveau, Philippe Guisset, Olivier Cazin, Marie Cécile Lasseur, Catherine Gabinsky, Claude Winnock, Stéphane Montaudon, Danièle Bedry, Régis Nouts, Caroline Pillet, Odile Benissan, Georges Gbikpi Favarel-Guarrigues, Jean Claude Castaing, Yves Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
title | Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
title_full | Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
title_fullStr | Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
title_full_unstemmed | Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
title_short | Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
title_sort | mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC374372/ https://www.ncbi.nlm.nih.gov/pubmed/14624691 |
work_keys_str_mv | AT levelclaude masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT chauveauphilippe masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT guissetolivier masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT cazinmariececile masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT lasseurcatherine masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT gabinskyclaude masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT winnockstephane masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT montaudondaniele masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT bedryregis masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT noutscaroline masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT pilletodile masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT benissangeorgesgbikpi masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT favarelguarriguesjeanclaude masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure AT castaingyves masstransferclearanceandplasmaconcentrationofprocalcitoninduringcontinuousvenovenoushemofiltrationinpatientswithsepticshockandacuteoliguricrenalfailure |